Pfizer/Astellas Take Off On New Xtandi Expansion With EMBARK Data

Astellas Has Said This Kind Of Trial Could Be More Challenging Under IRA

Pfizer/Astellas announced data from the Phase III EMBARK trial of Xtandi • Source: Shutterstock

More from Strategy

More from Business